Risk of hepatitis with various reintroduction regimens of anti-tubercular therapy: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Risk of hepatitis with various reintroduction regimens of anti-tubercular therapy: a systematic review and network meta-analysis

Published:2020-01-15 Issue:2 Volume:18 Page:171-179
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Soni Hariom¹^ORCID,Kumar-M Praveen¹^ORCID,Mishra Shubhra²^ORCID,Bellam Balaji L²^ORCID,Singh Harjeet³^ORCID,Mandavdhare Harshal S²^ORCID,Medhi Bikash¹^ORCID,Dutta Usha²^ORCID,Sharma Vishal²^ORCID

Affiliation:

1. Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1714436

Reference25 articles.

1. Treatment of pulmonary tuberculosis with short course chemotherapy in South India—5-year follow up

2. Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV

3. Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter?

4. Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced Hepatotoxicity

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets;Open Medicine;2024-01-01

3. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats;Journal of Complementary and Integrative Medicine;2023-12-25

4. Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort;Southern African Journal of HIV Medicine;2022-06-14

5. Antitubercular Therapy-Related Hepatitis;Tuberculosis of the Gastrointestinal system;2022